Literature DB >> 28945837

Nivolumab-induced asthma in a patient with non-small-cell lung cancer.

K Maeno1, S Fukuda2, T Oguri2, A Niimi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28945837     DOI： 10.1093/annonc/mdx455

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

1.  Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient.

Authors:  P Kissoonsingh; B Sutton; Syed U Iqbal; Lalit Pallan; Neil Steven; L Khoja
Journal:  Case Rep Oncol Med       Date:  2022-04-30

2.  Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: a case report.

Authors:  Masanori Harada; Hyogo Naoi; Kazuyo Yasuda; Yutaro Ito; Namio Kagoo; Tsutomu Kubota; Koshiro Ichijo; Eisuke Mochizuki; Masahiro Uehara; Shun Matsuura; Masaru Tsukui; Naoki Koshimizu
Journal:  BMC Pulm Med       Date:  2021-01-06       Impact factor: 3.317

3.  Respiratory system toxicity induced by immune checkpoint inhibitors: A real-world study based on the FDA adverse event reporting system database.

Authors:  Chanjuan Cui; Lei Deng; Wenqing Wang; Xiayang Ren; Yanfeng Wang; Wei Cui
Journal:  Front Oncol       Date:  2022-08-19       Impact factor: 5.738

4.  Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: Focus on Nivolumab.

Authors:  Hazim Bukamur; Heather Katz; Mohamed Alsharedi; Akram Alkrekshi; Yousef R Shweihat; Nancy J Munn
Journal:  South Med J       Date:  2020-11       Impact factor: 0.954
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.